Trademarkia Logo

Canada

C$
BIOFLUCISION & DESIGN
ADVERTISED

on 18 Sept 2024

Last Applicant/ Owned by

ASSURE TECH. (HANGZHOU) CO. LTD

3rd Floor, Building 4,No.1418-50, Moganshan RoadHangzhou City, Zhejiang Province, 310000

CN

Serial Number

2250928 filed on 10th Apr 2023

BIOFLUCISION & DESIGN

Trademark usage description

anti-inflammatory pharmaceutical preparations; anticoagulants; blood grouping reagents for medical purposes; chemical preparations for the diagnosis o Read More

Vienna Information


26 . 1 . 2

EllipsesEllipses

26 . 1 . 4

Two circles, two ellipses, one inside the otherDeux cercles, deux ellipses, l'un dans l'autre

26 . 1 . 18

Circles or ellipses containing one or more lettersCercles ou ellipses contenant une ou plusieurs lettres

26 . 1 . 19

Circles or ellipses with inscriptions projecting beyond the circumferenceCercles ou ellipses avec inscriptions débordant la circonférence

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

26 . 3 . 1

One triangleUn triangle

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Classification Information


Class [001]
Chemicals and adhesives


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [005]
Anti-inflammatory pharmaceutical preparations; anticoagulants; blood grouping reagents for medical purposes; chemical preparations for the diagnosis of pregnancy; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical purposes; diagnostic reagents and agents for medical diagnostic use; diagnostic reagents for medical purposes; diagnostic test reagents for medical purposes; digestive enzymes used to treat food allergies in pets; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting infections; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of blood disorders; reagent paper for medical purposes; reagents for use in medical genetic testing; reagents for use in medical testing for COVID-19 and other coronavirus diseases


Classification kind code

12

Class [010]
Analyzers for bacterial identification for medical purposes; blood drawing apparatus; blood gas analyzer; blood glucose meters; diagnostic biomolecule and DNA sequence detection devices for clinical medical purposes; diagnostic biomolecule and DNA sequence readers of biomolecule and DNA sequence testing results for clinical medical use; gene testing medical apparatus for identification of genus specific and species specific DNA and RNA sequences; medical apparatus and instruments for amplifying nucleic acid DNA and RNA molecules; medical devices for the qualitative detection of antibodies in human specimens collected as plasma or dried blood spots; medical ultrasound apparatus; polymerase chain reaction (PCR) tests for the detection of viruses in humans; radiotherapy apparatus; surgical instruments for veterinary use; ultrasonic medical diagnostic apparatus; x-ray apparatus for medical use


Classification kind code

12

Mark Details


Serial Number

2250928

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 18th Sept 2024
Advertised
Submitted for opposition 26
on 26th Aug 2024
Approved
Submitted for opposition 27
on 26th Aug 2024
Approval Notice Sent
Submitted for opposition 22
on 16th Aug 2024
Search Recorded
Submitted for opposition 30
on 10th Apr 2023
Filed
Submitted for opposition 1
on 10th Apr 2023
Created
Submitted for opposition 31
on 10th Apr 2023
Formalized